Ring 1
Ring 2
Ring 3
Ring 4

Mersana Therapeutics

Financing Rounds

  • Public
  • Exit
Round Led by Symbiosis
Round Led by Symbiosis

Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers.

View Website


  • Biologic


  • Oncology

Development Status

  • Phase 3+